Pharmacological Inhibition of Astrocytic Transglutaminase 2 Facilitates the Expression of a Neurosupportive Astrocyte Reactive Phenotype in Association with Increased Histone Acetylation
2024

Inhibiting Transglutaminase 2 in Astrocytes Helps Neurons Recover from Injury

publication 10 minutes Evidence: moderate

Author Information

Author(s): Delgado Thomas, Emerson Jacen, Hong Matthew, Keillor Jeffrey W., Johnson Gail V. W.

Primary Institution: University of Rochester

Hypothesis

TG2 mediates its influence on astrocytic phenotype through transcriptional regulation.

Conclusion

Inhibiting TG2 in astrocytes enhances their ability to support neuron growth and improves recovery after central nervous system injury.

Supporting Evidence

  • TG2 deletion in astrocytes improves their ability to support neurite outgrowth.
  • VA4 treatment of astrocytes mimics the effects of TG2 deletion.
  • Histone acetylation levels increase with TG2 inhibition, indicating enhanced gene expression.

Takeaway

When scientists blocked a protein called TG2 in brain support cells called astrocytes, these cells became better at helping injured neurons grow back.

Methodology

The study used a neuron-astrocyte co-culture model and pharmacological inhibition of TG2 with VA4 to assess changes in astrocytic function and gene expression.

Limitations

The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/biom14121594

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication